Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Seattle Genetics Initiates Two Phase I Trials of SGN-CD19A
Seattle Genetics Initiates Two Phase I Trials of SGN-CD19A
Seattle Genetics Initiates Two Phase I Trials of SGN-CD19A
Submitted by
admin
on February 6, 2013 - 11:07am
Source:
Yahoo
News Tags:
Seattle Genetics
SGN-CD19A
acute lymphoblastic leukemia
non-Hodgkin B-cell lymphoma
Headline:
Seattle Genetics Initiates Two Phase I Trials of SGN-CD19A
Do Not Allow Advertisers to Use My Personal information
